These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30746410)

  • 1. 22q11.2 Deletion Syndrome-Associated Parkinson's Disease.
    Boot E; Bassett AS; Marras C
    Mov Disord Clin Pract; 2019 Jan; 6(1):11-16. PubMed ID: 30746410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.
    Butcher NJ; Marras C; Pondal M; Rusjan P; Boot E; Christopher L; Repetto GM; Fritsch R; Chow EWC; Masellis M; Strafella AP; Lang AE; Bassett AS
    Brain; 2017 May; 140(5):1371-1383. PubMed ID: 28369257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications.
    Butcher NJ; Kiehl TR; Hazrati LN; Chow EW; Rogaeva E; Lang AE; Bassett AS
    JAMA Neurol; 2013 Nov; 70(11):1359-66. PubMed ID: 24018986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.
    Boot E; Butcher NJ; Udow S; Marras C; Mok KY; Kaneko S; Barrett MJ; Prontera P; Berman BD; Masellis M; Dufournet B; Nguyen K; Charles P; Mutez E; Danaila T; Jacquette A; Colin O; Drapier S; Borg M; Fiksinski AM; Vergaelen E; Swillen A; Vogels A; Plate A; Perandones C; Gasser T; Clerinx K; Bourdain F; Mills K; Williams NM; Wood NW; Booij J; Lang AE; Bassett AS;
    Neurology; 2018 Jun; 90(23):e2059-e2067. PubMed ID: 29752303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary α-Synuclein as a Candidate Biomarker of Parkinsonism in 22q11.2 Deletion Syndrome.
    Fanella M; Cerulli Irelli E; Accinni T; Di Fabio F; Putotto C; Pulvirenti F; Bellomi FE; Di Bonaventura C; Vivacqua G
    Mov Disord Clin Pract; 2024 Jul; 11(7):808-813. PubMed ID: 38661486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia.
    Van L; Boot E; Bassett AS
    Curr Opin Psychiatry; 2017 May; 30(3):191-196. PubMed ID: 28230630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychosis and movement disorders in an adolescent with 22q11.2 deletion syndrome].
    Zinkstok JR; Velders F; Rieken R; Houben M; Fiksinski A; van Amelsvoort TAMJ; Boot E
    Tijdschr Psychiatr; 2020; 62(3):229-233. PubMed ID: 32207133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome sequencing suggests mechanisms for 22q11.2 deletion-associated Parkinson's disease.
    Butcher NJ; Merico D; Zarrei M; Ogura L; Marshall CR; Chow EWC; Lang AE; Scherer SW; Bassett AS
    PLoS One; 2017; 12(4):e0173944. PubMed ID: 28430790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep psychophysiological phenotyping of adolescents and adults with 22q11.2 deletion syndrome: a multilevel approach to defining core disease processes.
    Parker DA; Cubells JF; Imes SL; Ruban GA; Henshey BT; Massa NM; Walker EF; Duncan EJ; Ousley OY
    BMC Psychiatry; 2023 Jun; 23(1):425. PubMed ID: 37312091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of 22q11.2 deletion syndrome in the relationship between congenital heart disease and scoliosis.
    Homans JF; de Reuver S; Heung T; Silversides CK; Oechslin EN; Houben ML; McDonald-McGinn DM; Kruyt MC; Castelein RM; Bassett AS
    Spine J; 2020 Jun; 20(6):956-963. PubMed ID: 31958577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter microstructural abnormalities of the cingulum bundle in youths with 22q11.2 deletion syndrome: associations with medication, neuropsychological function, and prodromal symptoms of psychosis.
    Kates WR; Olszewski AK; Gnirke MH; Kikinis Z; Nelson J; Antshel KM; Fremont W; Radoeva PD; Middleton FA; Shenton ME; Coman IL
    Schizophr Res; 2015 Jan; 161(1):76-84. PubMed ID: 25066496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11.2 deletion syndrome.
    Zafarullah M; Angkustsiri K; Quach A; Yeo S; Durbin-Johnson BP; Bowling H; Tassone F
    Metabolomics; 2024 Feb; 20(2):31. PubMed ID: 38418685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodromal symptoms in adolescents with 22q11.2 deletion syndrome and schizotypal personality disorder.
    Shapiro DI; Cubells JF; Ousley OY; Rockers K; Walker EF
    Schizophr Res; 2011 Jun; 129(1):20-8. PubMed ID: 21507614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study.
    Mekori-Domachevsky E; Guri Y; Yi J; Weisman O; Calkins ME; Tang SX; Gross R; McDonald-McGinn DM; Emanuel BS; Zackai EH; Zalsman G; Weizman A; Gur RC; Gur RE; Gothelf D
    Schizophr Res; 2017 Oct; 188():42-49. PubMed ID: 28041919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered functional brain dynamics in chromosome 22q11.2 deletion syndrome during facial affect processing.
    Cornblath EJ; Mahadevan A; He X; Ruparel K; Lydon-Staley DM; Moore TM; Gur RC; Zackai EH; Emanuel B; McDonald-McGinn DM; Wolf DH; Satterthwaite TD; Roalf DR; Gur RE; Bassett DS
    Mol Psychiatry; 2022 Feb; 27(2):1158-1166. PubMed ID: 34686764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome.
    Niarchou M; Moore TM; Tang SX; Calkins ME; McDonald-McGuinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    J Psychiatr Res; 2017 Sep; 92():124-131. PubMed ID: 28433949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep EEG in young people with 22q11.2 deletion syndrome: A cross-sectional study of slow-waves, spindles and correlations with memory and neurodevelopmental symptoms.
    Donnelly NA; Bartsch U; Moulding HA; Eaton C; Marston H; Hall JH; Hall J; Owen MJ; van den Bree MBM; Jones MW
    Elife; 2022 Aug; 11():. PubMed ID: 36039635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [22q11.2 microdeletion syndrome: Analysis of the care pathway before the genetic diagnosis].
    Ingrao T; Lambert L; Valduga M; Bosser G; Albuisson E; Leheup B
    Arch Pediatr; 2017 Nov; 24(11):1067-1075. PubMed ID: 28967605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review.
    de Boer J; Boot E; van Gils L; van Amelsvoort T; Zinkstok J
    Am J Med Genet A; 2019 Nov; 179(11):2292-2306. PubMed ID: 31407842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The motor profile of primary school-age children with a 22q11.2 deletion syndrome (22q11.2DS) and an age- and IQ-matched control group.
    Van Aken K; Caeyenberghs K; Smits-Engelsman B; Swillen A
    Child Neuropsychol; 2009 Nov; 15(6):532-42. PubMed ID: 19280375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.